TTY Biopharm Company Limited (TPEX: 4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
73.40
+0.40 (0.55%)
Nov 21, 2024, 1:30 PM CST

TTY Biopharm Company Cash Flow Statement

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
1,1201,1291,094831.89924.18900.08
Upgrade
Depreciation & Amortization
186.82193.1180.69162.79153.86148.56
Upgrade
Other Amortization
7.87.85.594.493.143.78
Upgrade
Loss (Gain) From Sale of Assets
2.691.933.280.740.320.58
Upgrade
Asset Writedown & Restructuring Costs
59.64116.180.734.154.5882.69
Upgrade
Loss (Gain) From Sale of Investments
35.7435.74-0.21-0.16-0.38
Upgrade
Loss (Gain) on Equity Investments
-159.76-131.34-116.38-135.18-162.8746.84
Upgrade
Provision & Write-off of Bad Debts
2.22-1.933.5613.58-0.1-5.5
Upgrade
Other Operating Activities
109.995.07110.34110.24-15.66100.98
Upgrade
Change in Accounts Receivable
-5.59-116.16-95.4-114.32-36.42-83.2
Upgrade
Change in Inventory
-78.2-56.75-83.95155.12-251.8-96.33
Upgrade
Change in Accounts Payable
-66.8911.9596.01-23.07-26.359.27
Upgrade
Change in Unearned Revenue
3.46-18.89-6.6423.48-0.398.26
Upgrade
Change in Other Net Operating Assets
-95.64-179.8943.55222.24-65.9894.22
Upgrade
Operating Cash Flow
1,1221,0851,2361,256526.351,210
Upgrade
Operating Cash Flow Growth
25.98%-12.17%-1.64%138.69%-56.49%12.67%
Upgrade
Capital Expenditures
-91.4-78.35-91.52-60.32-168.11-69.86
Upgrade
Sale of Property, Plant & Equipment
2.527.019.390.030.010.02
Upgrade
Cash Acquisitions
-242.87-----24.89
Upgrade
Sale (Purchase) of Intangibles
-13.74-21.23-43.98-13.84-13.75-0.78
Upgrade
Investment in Securities
197.86168.5534.68-14.1308.82-207.96
Upgrade
Other Investing Activities
-28.85-78.62-41.7-80.5620.2630.46
Upgrade
Investing Cash Flow
-176.48-2.63-133.14-168.78147.24-273.15
Upgrade
Short-Term Debt Issued
-10,28010,8905,4005,4007,700
Upgrade
Long-Term Debt Issued
-400430-720-
Upgrade
Total Debt Issued
10,05010,68011,3205,4006,1207,700
Upgrade
Short-Term Debt Repaid
--10,200-11,231-5,404-5,246-7,400
Upgrade
Long-Term Debt Repaid
--434.17-421.55-16.54-663.65-3.6
Upgrade
Total Debt Repaid
-9,953-10,634-11,653-5,421-5,910-7,404
Upgrade
Net Debt Issued (Repaid)
96.8345.83-332.62-20.54210.35296.4
Upgrade
Common Dividends Paid
-864.93-845.41-745.95-994.6-994.6-1,119
Upgrade
Other Financing Activities
-22.54-16.75-24.83-28.99-22.36-26.75
Upgrade
Financing Cash Flow
-790.64-816.33-1,103-1,044-806.61-849.27
Upgrade
Foreign Exchange Rate Adjustments
-20.09-2.66135.85-44.91-65.41-37.57
Upgrade
Net Cash Flow
134.89263.7135.07-1.48-198.4349.86
Upgrade
Free Cash Flow
1,0311,0071,1441,196358.251,140
Upgrade
Free Cash Flow Growth
27.61%-12.00%-4.33%233.86%-68.57%14.03%
Upgrade
Free Cash Flow Margin
17.69%18.29%22.61%26.37%8.49%25.52%
Upgrade
Free Cash Flow Per Share
4.134.044.604.801.444.58
Upgrade
Cash Interest Paid
34.9934.9923.2218.6719.615
Upgrade
Cash Income Tax Paid
283.71283.71277.92220.22311.47236.57
Upgrade
Levered Free Cash Flow
563.43737.63806.96980.02107.23812.46
Upgrade
Unlevered Free Cash Flow
586.77759.62821.24991.87119.36821.71
Upgrade
Change in Net Working Capital
335.23199.47-2.99-185.84454.1427.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.